Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc.
Federal Circuit Affirms Patent Invalidity for Erectile Dysfunction Drug
cafc · 2025-09-23 · Defendant Win · Impact: 30/100
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on September 23, 2025, resulted in a defendant win outcome. The core dispute involved the validity of a patent...